ABRAMS world trade wiki as a partner of UN Comtrade (database of the United Nations) as well as the OECD (Organisation for Economic Co-operation and Development) analyzes billions of statistical data as well as freight and customs data using intelligent algorithms as well as Artificial Intelligence (AI) and has developed a "unique business intelligence portal" on this basis (quote UN Comtrade / References).
On this page you will get insights into the market activities of Kalbio Global Medika which have been individually prepared by our research team.
ABRAMS world trade wiki not only shows direct suppliers and buyers of the first tier (Tier-1). Our tool Supply Chain Intelligence breaks the visibility barrier beyond Tier-1, enabling a comprehensive insight into the entire supply chain network, providing multi-tier transparency with just one click.



The performance of a company depends heavily on its suppliers. Therefore, a reliable network of partners (suppliers, dealers and manufacturers) is elementary. In bills of lading, a total of 73 international suppliers of Kalbio Global Medika could be identified on which the company is relying. One of the suppliers is, for example, the company Nuova Ompi S.R.L. Unipersonale, which delivered 5 shipments.
Among 14 identified supplying countries, an important source to purchase products from is: Italy. 56 shipments of goods could be identified from this country.
Get an overview of Kalbio Global Medika’s international procurement and its 73 suppliers with Company Transparency
Generally you can differentiate the supply chain or supply network of Kalbio Global Medika by two perspectives:
To ensure business stability and continuity, a supply chain or supply network must be constructed in such a way that external influences can cause as little damage as possible to Kalbio Global Medika. This applies both in the area of procurement (the loss of a supplier must be covered by an alternative supplier) as in the area of sales (the loss of a buyer must be covered by an alternative buyer).
Risks can generally be considered as the non-availability of goods, through cutback or complete halt of production, or the potential loss of business partners, violating compliance rules (e.g. protection of the environment, labor legislation) and thus drop out of the supply network.
This risk should not necessarily be limited to the direct business partner (Tier 1), it involves the entire supply chain, unless sufficient alternative suppliers and buyers have been put in place.
Get an overview of the international supply chain of Kalbio Global Medika (upstream/procurement and downstream/sales) from Tier-1 to Tier-n
E.G.: Tier 1 supplier Nuova Ompi S.R.L. UnipersonaleTier-1 Buyer Bioneeds India Pvt. Ltd.
ABRAMS world trade wiki not only shows direct suppliers and customers of the first tier (Tier-1). With just one click in our tool Supply Chain Intelligence you get a comprehensive insight into the supply network with multiple tiers (Tier-n) beyond the first tier.
Each tier in the supply chain or supply network on the supplier side of Kalbio Global Medika involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.
If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:
Analyze the potential of shortening and therefore stabilizing the supply chain of Kalbio Global Medika
Based on the analysis of international bills of lading (bill of lading/ bills of lading/ BOL), a total of 57 different product categories that have been purchased by Kalbio Global Medika, can be identified.
These are classified by means of HS codes (HTS codes or customs tariff numbers).
For example, HS code 401490 classifies the following products:
„Hygienic or pharmaceutical articles, incl. teats, of vulcanised rubber (excl. hard rubber), with or without fittings of hard rubber, n.e.s. (excl. sheath contraceptives and articles of apparel and clothing accessories, incl. gloves, for all purposes)". This HS code was sighted 30 times in total.
From the product descriptions of the analyzed bills of lading (bill of lading/ bills of lading/ BOL), the following purchased products from various suppliers can be identified as examples:
Get an overview of internationally purchased products by Kalbio Global Medika with Company Transparency
Each tier in the supply chain or supply network of Kalbio Global Medika is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.
If e.g. a Tier-1 supplier from Kalbio Global Medika that primarily trades a product and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain and reduce purchasing costs. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:
Analyze the potential of shortening the supply chain of Kalbio Global Medika and saving costs on the procurement side.
The performance of a company depends fundamentally on its buyers. Therefore, a largest possible base of stable buyers is crucial. A total of 30 international buyers of Kalbio Global Medika could be identified in bills of lading. For example, one of the buyers is the company Bioneeds India Pvt. Ltd., which has received 7 shipments.
Among 14 identified buying countries, an important target country to sell products to is: India. 73 shipments of goods were shipped to this country in the period covered.
Get an overview of the international sales and its 30 buyers of Kalbio Global Medika with Company Transparency.
Based on the analysis of international bills of lading (bill of lading/ bills of lading/ BOL), a total of 11 different product categories sold by Kalbio Global Medika, can be identified.
These are classified by means of HS codes (HTS codes or customs tariff numbers).
For example, HS code 3504 classifies the following products:
„Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed". This HS code was sighted 101 times in total.
From the product descriptions of the analyzed bills of lading (bill of lading/ bills of lading/ BOL), the following sold product can be identified:
Get an overview of internationally sold products by Kalbio Global Medika with Company Transparency
Each tier in the buyer side of the supply chain or supply network of Kalbio Global Medika is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.
If e.g. a Tier-1 buyer from Kalbio Global Medika that primarily trades products and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain downstream giving a potential to optimize profit margins for Kalbio Global Medika. A previous Tier-2 buyer now turns into a Tier-1 buyer, which we call "go-direct". In our tool Supply chain Intelligence as far as international buyers are concerned, this analysis can be done with one click:
Analyze the potential to shorten the supply chain and optimize the profit margins on the sales side of Kalbio Global Medika
Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as Kalbio Global Medika can itself reliably deliver due to external dependencies (exogenous factors).
To assess this, data analysis should be conducted to get practical answers:
How is the supply chain or supply network structured on the supplier side of Kalbio Global Medika? Are there suppliers or products in the supply chain that are reported as critical, e.g. in international media?
Which buyers does Kalbio Global Medika consistently sell to over a long period of time that can be identified as a good reference?
The more constant outgoing shipments of a company’s, the easier it is to assess potential problems for a supplier like Kalbio Global Medika
Operational aspects like a stable supply chain, an in-house production and reliable logistics define sustainable performance.
Since 2021, global supply shortages have increasingly added external factors as to whether a supplier like Kalbio Global Medika can deliver reliably itself through dependencies.
Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) the current supply and performance capacity can be indirectly analyzed.
Here you can see an analysis of shipments by Kalbio Global Medika to international buyers in the last few months with Company Transparency
The more constant incoming shipments, the better one can determine possible procurement problems of a company like Kalbio Global Medika
Since 2021, there are increasingly external factors due to global supply shortages, whether a company, no matter manufacturer or distributor, can reliably deliver through dependencies.
Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) it is possible to analyze current procurement stability and thus ultimately also to derive an indication of the company’s delivery and performance capability.
Here you can see an analysis of shipments from international suppliers to Kalbio Global Medika in the last few months with Company Transparency
Sourcing products as regionally as possible with short shipping routes and the use of sustainable materials define the CO₂ footprint and sustainability of the products of any company, including Kalbio Global Medika
After many companies, predominantly due to cost savings, have been building their networks increasingly internationally for years, there is now an increasing trend of so-called “on-shoring” or “near-shoring”. Attempting to include suppliers who are the closest to the supply chain because of financial, risk, environmental and image aspects:
Based on the development of current shipments (in terms of number of shipments and quantity of goods) and changes in international suppliers and routes, it is possible to analyze the extent to which Kalbio Global Medika has already made efforts in recent months and years, to focus on environmentally relevant aspects, like carbon footprint and sustainability in its business activities.
Get an overview of the international shipments that have an impact on the CO₂ footprint, as well as the sustainability of Kalbio Global Medika
Generally you can differentiate the competition of Kalbio Global Medika by the purchase and sales perspective.
Competitors of Kalbio Global Medika on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 401490, 392390) or by top product terms.
Competitors on the sales side of Kalbio Global Medika (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes (e.g. 3504, 300212) or by top product terms.
Following companies buy similar products like Kalbio Global Medika:
Following companies sell similar products like Kalbio Global Medika: